Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Showing 13 of 0 results

Not applicableLooking for participantsNCT07120997
What this trial is testing

Prunes Preventing Bone Loss in Perimenopause

Who this might be right for
Perimenopausal Bone Loss
Penn State University 124
Post-approval studies (Phase 4)Study completedNCT00545480
What this trial is testing

SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 596
Not applicableStudy completedNCT00665860
What this trial is testing

Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone Loss

Who this might be right for
Osteoporosis
Baylor College of Medicine 403
Large-scale testing (Phase 3)Study completedNCT05395091
What this trial is testing

Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND

Who this might be right for
Osteoporosis, Postmenopausal
Alvotech Swiss AG 532
Post-approval studies (Phase 4)Study completedNCT05361408
What this trial is testing

A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)

Who this might be right for
Osteoporosis
Yonsei University 114
Testing effectiveness (Phase 2)UnknownNCT03720886
What this trial is testing

G56W1 in Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd. 148
Large-scale testing (Phase 3)Study completedNCT00355953
What this trial is testing

Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women

Who this might be right for
MenopauseOsteopenia
University of Messina 400
Testing effectiveness (Phase 2)UnknownNCT01834105
What this trial is testing

Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1

Who this might be right for
Postmenopausal Osteoporosis
Fujian Academy of Traditional Chinese Medicine 25
Large-scale testing (Phase 3)Study completedNCT06770894
What this trial is testing

DPP4-Inhibitors and Bone Metabolism in Diabetes

Who this might be right for
OsteoporosisBone Loss, PostmenopausalDiabetes Mellitus Type 2
Azienda Policlinico Umberto I 132
Not applicableNot Yet RecruitingNCT07402772
What this trial is testing

Female Osteoporosis

Who this might be right for
Female Osteoporosis
Kayseri City Hospital 1,500
Not applicableWithdrawnNCT03812367
What this trial is testing

Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid

Who this might be right for
Osteoporosis, Postmenopausal
University of California, Davis
Large-scale testing (Phase 3)Study completedNCT00670501
What this trial is testing

Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 1,637
Post-approval studies (Phase 4)Study completedNCT00532428
What this trial is testing

Long Term Effects of Raloxifene Treatment on Bone Quality

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 31

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation